BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6217214)

  • 21. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
    Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
    Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
    Tedder TF; Clement LT; Cooper MD
    J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.
    Thompson JJ; Herlyn MF; Elder DE; Clark WH; Steplewski Z; Koprowski H
    Am J Pathol; 1982 Jun; 107(3):357-61. PubMed ID: 6177248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunoarchitecture of cutaneous pseudolymphoma.
    Wirt DP; Grogan TM; Jolley CS; Rangel CS; Payne CM; Hansen RC; Lynch PJ; Schuchardt M
    Hum Pathol; 1985 May; 16(5):492-510. PubMed ID: 3157635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101.
    Goldman-Leikin RE; Kaplan EH; Zimmer AM; Kazikiewicz J; Manzel LJ; Rosen ST
    Exp Hematol; 1988 Nov; 16(10):861-4. PubMed ID: 3262528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ study of T-cell subpopulations in cutaneous T-cell lymphoma. Diagnostic criteria.
    Chu A; Patterson J; Berger C; Vonderheid E; Edelson R
    Cancer; 1984 Dec; 54(11):2414-22. PubMed ID: 6388804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies against Epstein-Barr virus transformed B lymphocytes from a CLL patient.
    Guha AK; Ghose T; Luner SJ; Nolido-Cruz H; Uniyal S; Rajaraman R; Fernandez LA; Lee SS; Lee CL
    Hybridoma; 1990 Apr; 9(2):119-32. PubMed ID: 2161403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
    Tong AW; Lee J; Stone MJ
    Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
    Fukunaga Y; Evans SS; Yamamoto M; Ueda Y; Tamura K; Takakuwa T; Gebhard D; Allopenna J; Demaria S; Clarkson B
    Blood; 1989 Nov; 74(7):2486-92. PubMed ID: 2553165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma.
    Vonderheid EC; Tan E; Sobel EL; Schwab E; Micaily B; Jegasothy BV
    J Am Acad Dermatol; 1987 Jul; 17(1):40-52. PubMed ID: 2956298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus sera antilymphocyte reactivity: detection of antibodies to Tac-antigen positive T cell lines.
    Sano H; Kumagai S; Namiuchi S; Uchiyama T; Yodoi J; Maeda M; Takatsuki K; Suginoshita T; Imura H
    Clin Exp Immunol; 1986 Jan; 63(1):8-16. PubMed ID: 3006953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
    Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
    J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
    Takeuchi T; Barcos MP; Seon BK
    Cancer Res; 1991 Jun; 51(11):2985-93. PubMed ID: 1709587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells.
    Haynes BF; Metzgar RS; Minna JD; Bunn PA
    N Engl J Med; 1981 May; 304(22):1319-23. PubMed ID: 6971410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody directed to human T-cell malignancy antigen.
    Minegishi M; Tsuchiya S; Minegishi N; Yoshie O; Konno T
    Leuk Res; 1989; 13(1):43-51. PubMed ID: 2783754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coincidence of B-cell chronic lymphocytic leukemia and cutaneous T-cell lymphoma (mycosis fungoides): immunologic characterization by monoclonal antibodies.
    Sheibani K; Forman SJ; Winberg CD; Rappaport H
    Blood; 1983 Dec; 62(6):1176-81. PubMed ID: 6416333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
    Gougos A; Letarte M
    J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-helper cell lymphoma involving the lymph nodes and skin. A clinical, morphologic, and immunohistochemical analysis of five cases.
    van den Oord JJ; De Wolf-Peeters C; Frizzera G; Desmet VJ; Tricot G; Thomas J; Marien K; Gatter KC; Mason DY
    Cancer; 1985 Apr; 55(8):1714-21. PubMed ID: 2579720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Its application to paraffin-embedded tissues.
    Yoshino T; Mukuzono H; Aoki H; Takahashi K; Takeuchi T; Kubonishi I; Ohtsuki Y; Motoi M; Akagi T
    Am J Pathol; 1989 Jun; 134(6):1339-46. PubMed ID: 2527008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.